Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

PURPOSE: To study the effect of interferon-α2 auto-antibodies (IFN-α2 Abs) on clinical and virological outcomes in critically ill COVID-19 patients and the risk of IFN-α2 Abs transfer during convalescent plasma treatment. METHODS: Sera from healthy controls, cases of COVID-19, and other respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Raadsen, Matthijs P., Gharbharan, Arvind, Jordans, Carlijn C. E., Mykytyn, Anna Z., Lamers, Mart M., van den Doel, Petra B., Endeman, Henrik, van den Akker, Johannes P. C., GeurtsvanKessel, Corine H., Koopmans, Marion P. G., Rokx, Casper, Goeijenbier, Marco, van Gorp, Eric C. M., Rijnders, Bart J. A., Haagmans, Bart L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586830/
https://www.ncbi.nlm.nih.gov/pubmed/34767118
http://dx.doi.org/10.1007/s10875-021-01168-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586830/
https://www.ncbi.nlm.nih.gov/pubmed/34767118
http://dx.doi.org/10.1007/s10875-021-01168-3

Ejemplares similares